摘要:
springer.com
sci-hub.se 参考文章(6)
H. Kopera, Consensus on preventing osteoporosis BMJ. ,vol. 295, pp. 1277- 1277 ,(1987) , 10.1136/BMJ.295.6608.1277
P. Geusens, J. Dequeker, A. Verstraeten, J. Nijs, M. Van Holsbeeck, Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions Maturitas. ,vol. 8, pp. 281- 289 ,(1986) , 10.1016/0378-5122(86)90036-8
B E C Nordin, A G Need, H A Morris, M Horowitz, Consensus on preventing osteoporosis BMJ. ,vol. 295, pp. 1276- 1277 ,(1987) , 10.1136/BMJ.295.6608.1276-A
A. G. Need, H. A. Morris, T. F. Hartley, M. Horowitz, B. E. C. Nordin, Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women. Calcified Tissue International. ,vol. 41, pp. 7- 10 ,(1987) , 10.1007/BF02555124
A.G. Need, B.E. Chatterton, Cynthia J. Walker, Tracy A. Steurer, M. Horowitz, B.E.C. Nordin, Comparison of calcium, calcitriol, ovarian hormones and nandrolone in the treatment of osteoporosis Maturitas. ,vol. 8, pp. 275- 280 ,(1986) , 10.1016/0378-5122(86)90035-6
Dequeker J, Geusens P, Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study. Bone and Mineral. ,vol. 1, pp. 347- ,(1986)